Arnett, F.C., Cho, M., Chatterjee, S., Aguilar, M.B., Reveille, J.D. and Mayes, M.D. (2001) Familial Occurrence Frequencies and Relative Risks for Systemic Clerosis (Scleroderma) in Three United States Cohorts. Arthritis & Rheumatism, 44, 1359-1362.
http://dx.doi.org/10.1002/1529-0131(200106)44:6<1359::AID-ART228>3.0.CO;2-S

has been cited by the following article:

• TITLE: Anti-RNA Polymerase III Antibodies in Systemic Sclerosis

  AUTHORS: Andrew Kelly, Chris T. Derk

  KEYWORDS: Autoantibodies, Systemic Sclerosis, Scleroderma, Anti-RNA Polymerase III, Cancer

  JOURNAL NAME: Open Journal of Rheumatology and Autoimmune Diseases, Vol.5 No.3, August 19, 2015

  ABSTRACT: Anti-RNA Polymerase III has been recognized as an important autoantibody in Systemic Sclerosis and it is now included in the 2013 ACR/EULAR classification criteria for Systemic Sclerosis. With this manuscript we attempt to review the current data on anti-RNA polymerase II as it relates to Systemic Sclerosis.